Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

about

A cure is possible: a study of 10-year survivors of brain metastases.Case Report of Extended Survival and Quality of Life in a Melanoma Patient with Multiple Brain Metastases and Review of Literature.

P2860

Q48604302-65F82F7B-580D-4EBE-96EE-77C6B848F4E4 Q50300035-597CF919-9D0B-4B02-95A9-4686A5F9855E

P2860

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

Item

http://www.wikidata.org/entity/Q35849079

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Somatic and germline analyses ...... a recurrent brain metastasis.

@ast

Somatic and germline analyses ...... a recurrent brain metastasis.

@en

type

Item

label

Somatic and germline analyses ...... a recurrent brain metastasis.

@ast

Somatic and germline analyses ...... a recurrent brain metastasis.

@en

prefLabel

Somatic and germline analyses ...... a recurrent brain metastasis.

@ast

Somatic and germline analyses ...... a recurrent brain metastasis.

@en

P1476

Somatic and germline analyses ...... a recurrent brain metastasis.

@en

P2093

Anna Pavlick

http://www.w3.org/2001/XMLSchema#string

David Polsky

http://www.w3.org/2001/XMLSchema#string

Farbod Darvishian

http://www.w3.org/2001/XMLSchema#string

Iman Osman

http://www.w3.org/2001/XMLSchema#string

John Golfinos

http://www.w3.org/2001/XMLSchema#string

Jyothi Tadepalli

http://www.w3.org/2001/XMLSchema#string

Richard Shapiro

http://www.w3.org/2001/XMLSchema#string

Sarah Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

NRAS mutation status is an independent prognostic factor in metastatic melanoma.

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

Cancer statistics, 2014

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

IL-10 elicits IFNγ-dependent tumor immune surveillance.

Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target

Melanoma risk loci as determinants of melanoma recurrence and survival

Clinical correlates of NRAS and BRAF mutations in primary human melanoma.

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival

P2888

s12885-015-1927-0

P304

926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1927-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomas Kirchhoff

P577

2015-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284560068

http://www.w3.org/2001/XMLSchema#string

P6179

1052667830

http://www.w3.org/2001/XMLSchema#string

P698

26597176

http://www.w3.org/2001/XMLSchema#string

P932

4657192

http://www.w3.org/2001/XMLSchema#string

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

about

P2860

P2860

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932